S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.28 (+0.65%)
AAPL   116.76 (+1.49%)
MSFT   214.96 (+2.32%)
FB   283.46 (+2.29%)
GOOGL   1,598.00 (+0.87%)
AMZN   3,282.60 (+2.36%)
TSLA   424.00 (+0.89%)
NVDA   535.27 (+1.83%)
BABA   317.49 (+3.46%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   79.50 (-3.32%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.64 (+0.08%)
NIO   28.48 (+9.50%)
BA   155.00 (-3.62%)
DIS   123.16 (-0.73%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.28 (+0.65%)
AAPL   116.76 (+1.49%)
MSFT   214.96 (+2.32%)
FB   283.46 (+2.29%)
GOOGL   1,598.00 (+0.87%)
AMZN   3,282.60 (+2.36%)
TSLA   424.00 (+0.89%)
NVDA   535.27 (+1.83%)
BABA   317.49 (+3.46%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   79.50 (-3.32%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.64 (+0.08%)
NIO   28.48 (+9.50%)
BA   155.00 (-3.62%)
DIS   123.16 (-0.73%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.28 (+0.65%)
AAPL   116.76 (+1.49%)
MSFT   214.96 (+2.32%)
FB   283.46 (+2.29%)
GOOGL   1,598.00 (+0.87%)
AMZN   3,282.60 (+2.36%)
TSLA   424.00 (+0.89%)
NVDA   535.27 (+1.83%)
BABA   317.49 (+3.46%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   79.50 (-3.32%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.64 (+0.08%)
NIO   28.48 (+9.50%)
BA   155.00 (-3.62%)
DIS   123.16 (-0.73%)
S&P 500   3,390.68 (-0.30%)
DOW   27,463.19 (-0.80%)
QQQ   282.28 (+0.65%)
AAPL   116.76 (+1.49%)
MSFT   214.96 (+2.32%)
FB   283.46 (+2.29%)
GOOGL   1,598.00 (+0.87%)
AMZN   3,282.60 (+2.36%)
TSLA   424.00 (+0.89%)
NVDA   535.27 (+1.83%)
BABA   317.49 (+3.46%)
CGC   18.58 (+0.27%)
GE   7.11 (-3.66%)
MU   51.96 (-0.35%)
AMD   79.50 (-3.32%)
T   26.91 (-1.72%)
F   7.91 (-1.49%)
ACB   3.99 (-9.32%)
GILD   60.00 (+0.07%)
NFLX   488.64 (+0.08%)
NIO   28.48 (+9.50%)
BA   155.00 (-3.62%)
DIS   123.16 (-0.73%)
Log in
NYSE:CCJ

Cameco Stock Forecast, Price & News

$9.59
0.00 (0.00 %)
(As of 10/27/2020 03:59 PM ET)
Add
Compare
Today's Range
$9.53
Now: $9.59
$9.67
50-Day Range
$9.26
MA: $10.10
$11.28
52-Week Range
$5.30
Now: $9.59
$12.33
Volume127,429 shs
Average Volume1.62 million shs
Market Capitalization$3.80 billion
P/E Ratio106.56
Dividend Yield0.62%
Beta0.99
Cameco Corporation produces and sells uranium. The company operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. Its operating uranium property is the Cigar Lake property located in Saskatchewan, Canada. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles and reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
Read More
Cameco logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous metal ores
Sub-IndustryN/A
CUSIPN/A
Phone306-956-6200
Employees1,885

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 billion
Cash Flow$0.59 per share
Book Value$9.51 per share

Profitability

Net Income$55.77 million

Miscellaneous

Market Cap$3.80 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$9.59
0.00 (0.00 %)
(As of 10/27/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CCJ News and Ratings via Email

Sign-up to receive the latest news and ratings for CCJ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cameco (NYSE:CCJ) Frequently Asked Questions

How has Cameco's stock been impacted by Coronavirus (COVID-19)?

Cameco's stock was trading at $7.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CCJ stock has increased by 37.0% and is now trading at $9.62.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Cameco?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cameco in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cameco
.

When is Cameco's next earnings date?

Cameco is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Cameco
.

How can I listen to Cameco's earnings call?

Cameco will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Cameco's earnings last quarter?

Cameco Co. (NYSE:CCJ) posted its quarterly earnings results on Wednesday, July, 29th. The basic materials company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.11. The basic materials company earned $525 million during the quarter, compared to analyst estimates of $414.76 million. Cameco had a return on equity of 1.21% and a net margin of 2.26%. The business's revenue was up 35.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.04) EPS.
View Cameco's earnings history
.

How often does Cameco pay dividends? What is the dividend yield for Cameco?

Cameco declared an annual dividend on Friday, November 1st. Investors of record on Wednesday, November 27th will be given a dividend of $0.122 per share on Friday, December 13th. This represents a dividend yield of 1.24%. The ex-dividend date of this dividend is Tuesday, November 26th. This is a boost from Cameco's previous annual dividend of $0.06.
View Cameco's dividend history
.

What price target have analysts set for CCJ?

6 Wall Street analysts have issued twelve-month price objectives for Cameco's shares. Their forecasts range from $13.00 to $16.00. On average, they expect Cameco's stock price to reach $14.10 in the next year. This suggests a possible upside of 46.6% from the stock's current price.
View analysts' price targets for Cameco
.

Are investors shorting Cameco?

Cameco saw a drop in short interest in September. As of September 15th, there was short interest totaling 13,290,000 shares, a drop of 14.7% from the August 31st total of 15,580,000 shares. Based on an average daily volume of 2,480,000 shares, the short-interest ratio is currently 5.4 days. Currently, 3.4% of the shares of the stock are sold short.
View Cameco's Short Interest
.

Who are some of Cameco's key competitors?

What other stocks do shareholders of Cameco own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cameco investors own include Cameco (CCO), Freeport-McMoRan (FCX), General Electric (GE), Intel (INTC), Energy Transfer (ET), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Ford Motor (F), Gilead Sciences (GILD) and Barrick Gold (GOLD).

Who are Cameco's key executives?

Cameco's management team includes the following people:
  • Mr. Timothy S. Gitzel, Pres, CEO & Director (Age 57)
  • Grant E. Isaac, Sr. VP & CFO
  • Mr. Brian Arthur Reilly B.Sc., M.Sc., M.B.A., P.Geo., Sr. VP & COO
  • Mr. Sean Anthony Quinn, Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Alice Louise Wong, Sr. VP & Chief Corp. Officer
  • Ms. Rachelle Girard, Director of Investor Relations
  • Mr. Scott McHardy, Director of North American Exploration & VP of Exploration
  • Ms. Heidi Shockey, Vice-Pres & Controller
  • Ms. Leah Hipperson, Mang. of Treasury & Insurance

What is Cameco's stock symbol?

Cameco trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCJ."

Who are Cameco's major shareholders?

Cameco's stock is owned by a variety of retail and institutional investors. Top institutional investors include Alberta Investment Management Corp (0.34%), Assenagon Asset Management S.A. (0.29%), Foundation Resource Management Inc. (0.14%), Pinnacle Associates Ltd. (0.10%), American Trust Investment Advisors LLC (0.06%) and Exane Derivatives (0.03%).

Which major investors are selling Cameco stock?

CCJ stock was sold by a variety of institutional investors in the last quarter, including Pinnacle Associates Ltd., Crossmark Global Holdings Inc., and Creative Financial Designs Inc. ADV.

Which major investors are buying Cameco stock?

CCJ stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., American Trust Investment Advisors LLC, Alberta Investment Management Corp, Exane Derivatives, Exane Derivatives, Bradley Foster & Sargent Inc. CT, D. B. Root & Company LLC, and Envestnet Asset Management Inc..

How do I buy shares of Cameco?

Shares of CCJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cameco's stock price today?

One share of CCJ stock can currently be purchased for approximately $9.62.

How big of a company is Cameco?

Cameco has a market capitalization of $3.81 billion and generates $1.40 billion in revenue each year. The basic materials company earns $55.77 million in net income (profit) each year or $0.08 on an earnings per share basis. Cameco employs 1,885 workers across the globe.

What is Cameco's official website?

The official website for Cameco is www.cameco.com.

How can I contact Cameco?

Cameco's mailing address is 2121 11TH ST W, SASKATOON A9, S7M 1J3. The basic materials company can be reached via phone at 306-956-6200.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.